f i in
🔍

Lipad Inj. 20mg

Lipad (Pegylated Liposomal Doxorubicin) offers a safer delivery of doxorubicin — a safe change in oncology — for ovarian cancer, Kaposi’s sarcoma and multiple myeloma.

Lipad Inj. 20mg

Lipad Inj. 20mg

Generic Name: Pegylated Liposomal Doxorubicin

Indications

  • Ovarian cancer after failure of platinum-based chemotherapy.
  • AIDS-related Kaposi’s sarcoma.
  • Multiple myeloma in combination therapy.

Strength: 20 mg

Pack Size: Vial

Dosage Form: Dispersion for infusion

Categories: Pharmaceuticals

Therapeutic Class: Anthracycline (Liposomal)

Products Information

OUR PROMISE TO OUR PEOPLE

Our Partners

Business Relationship

At Amgomed, we recognize that robust business relationships are pivotal in delivering superior healthcare solutions. As an established entity in the pharmaceutical industry, we have cultivated enduring partnerships with global manufacturers to introduce innovative oncology products to patients across Pakistan.